Prescriber's Corner

Ibrutinib in Relapsed or Refractory Mantle Cell Lymphoma and Chronic Lymphocytic Leukemia

Derek Peterson, PharmD(c), and Joanna Schwartz, BCOP, PharmD

Albany College of Pharmacy and Health Sciences, Colchester, Vermont, and Fletcher Allen Healthcare, Burlington, Vermont

Derek Peterson, PharmD(c), 261 Mountain View Drive, Colchester, VT 05446. E-mail: derek.peterson@acphs.edu


J Adv Pract Oncol 2014;5:348–354 | DOI: 10.6004/jadpro.2014.5.5.5 | © 2014 Harborside Press®


  



For access to the full length article, please sign in.

Section Seperator
ADVERTISEMENT
Section Seperator
ADVERTISEMENT
Section Seperator
ADVERTISEMENT
Section Seperator
Copyright © 2010-2018 Harborside Press, LLC All rights reserved.               
Home | Current Issue | Previous Issue | Submissions | About JADPRO | Advertising | Privacy Policy | Contact | Copyright Notice/Disclaimer | Subscribe
Bot trap - Don't go here
By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.